{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:32:12Z","timestamp":1790742732264,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ology Bioservices Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.041","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:27:51Z","timestamp":1585762071000},"page":"3639-3645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor"],"prefix":"10.1016","volume":"38","author":[{"given":"Dalton M.","family":"Berrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin C.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.041_b0005","article-title":"Viral vector production in the integrity\u00ae iCELLis\u00ae","author":"Lennaertz","year":"2013","journal-title":"BMC Proc"},{"key":"10.1016\/j.vaccine.2020.03.041_b0010","unstructured":"Legmann R. Case study: single-use platform for complete process development and scale-up of an adenovirus. Pall Life Sciences."},{"key":"10.1016\/j.vaccine.2020.03.041_b0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biotechadv.2006.08.004","article-title":"Packed-bed bioreactors for mammalian cell culture","author":"Meuwly","year":"2007","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.vaccine.2020.03.041_b0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/bp000162z","article-title":"Comparison of different bioreactor systems for the production of","author":"Merten","year":"2001","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2020.03.041_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13568-014-0025-z","article-title":"Assessment of packed bed bioreactor systems in the production of viral vaccines","author":"Rajendran","year":"2014","journal-title":"AMB Exp"},{"key":"10.1016\/j.vaccine.2020.03.041_b0030","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","article-title":"Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production","author":"Tapia","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2020.03.041_b0035","series-title":"Chapter 1 - Tissue Engineering: An Introduction","author":"Moroni","year":"2014"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.041_b0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2020.03.041_b0045","doi-asserted-by":"crossref","unstructured":"Fine SM. Vesicular stomatitis virus and related vesiculoviruses, 8th ed., vol. 2; 2015, p. 1981\u201383.","DOI":"10.1016\/B978-1-4557-4801-3.00164-8"},{"key":"10.1016\/j.vaccine.2020.03.041_b0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-373741-0.50007-6","article-title":"Minus-strand RNA viruses","author":"Strauss","year":"2008","journal-title":"Virs Human Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2020.03.041_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001127","article-title":"The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis","volume":"6","author":"Cureton","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.03.041_b0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.041_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of lassa fever","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.03.041_b0070","doi-asserted-by":"crossref","unstructured":"Monath T, Fast P, Modjarrad K, Clarke D, Martin D, Fusco J, Nichols R, et al. rVSVdG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk\/benefit assessment, vol. 1; 2019.","DOI":"10.1016\/j.jvacx.2019.100009"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.041_b0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/humc.2017.015","article-title":"Oncolytic recombinant vesicular stomatitis virus (VSV) is nonpathogenic and nontransmissible in pigs, a natural host of VSV","volume":"28","author":"Velazquez-Salinas","year":"2017","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"8","key":"10.1016\/j.vaccine.2020.03.041_b0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00109-012-0863-6","article-title":"Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy","volume":"90","author":"Muik","year":"2012","journal-title":"J Mol Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:38Z","timestamp":1759401758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":16,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20304205"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}